Publications
Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
1 November 2010
In December 2006, the National Institute for Health and Clinical Excellence (NICE) issued guidance for preventing and managing overweight and obesit. Recommendations are step-wise, starting with…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and…
Using QALYs in Cancer: Review of the Methodological Limitations
1 October 2010
Current methods for constructing quality adjusted life year (QALY) measurements may be deficient for cancer patients in three respects: descriptions of health state, valuation of health…
Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe
1 October 2010
Ten member companies of the EFPIA HTA Task Force commissioned OHE consulting to provide research, data and analysis that would enable EFPIA both to support and…
New Drugs to Tackle Antimicrobial Resistance: EU Policy Options
1 October 2010
Antimicrobial resistance (AMR) to drugs, a natural and unavoidable consequence of treating infectious diseases, is a growing global public health threat. The EU Commission is to…
Enhancing the Benefits from Biomedical and Health Research Spillovers
1 October 2010
Research spillovers may exist when research by one organisation creates increased output for other organisations that operate in the same or another sector of the economy. …
US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?
1 September 2010
The speaker for the OHE’s 17th Annual Lecture was Dr Alan Garber, Director both of Stanford University’s Center for Health Policy and its Center for Primary…
Innovation in Medicines: Can We Value Progress?
1 August 2010
Summarised in this publication are the main points and conclusions from a discussion facilitated by OHE that focused on innovation in the pharmaceutical industry. Participants included…